Clinical Trial Update: Safety of Lixivaptan in Subjects Previously Treated With Tolvaptan for Autosomal Dominant Polycystic Kidney Disease [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety of lixivaptan in adults with autosomal dominant polycystic kidney disease previously treated with tolvaptan; study terminated wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autosomal Dominant Polycystic Kidney Disease
• Polycystic Kidney Disease

Drugs mentioned

• Lixivaptan (lixivaptan)
• tolvaptan (tolvaptan)

Snippet

Sponsor: Palladio Biosciences | Conditions: Polycystic Kidney Disease, Adult, ADPKD | Phase 3 | Status: TERMINATED | Results posted: 2023-04-10